Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Acute encephalopathy with biphasic seizures and late reduced diffusion in a Spanish girl
Miguel García-Boyano1, José Manuel Caballero-Caballero1, Marina Alguacil-Guillén1
1Hospital Universitario La Paz, Madrid, Spain.
Insights
This case study details acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in a child. Procalcitonin and CRP levels, along with MR spectroscopy, aided early diagnosis and outcome prediction.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a rare neurological condition.
- Early diagnosis and understanding of AESD are crucial for patient outcomes.
- Biomarkers and neuroimaging play a key role in diagnosing and managing neurological disorders in children.
Observation:
- A 22-month-old Spanish girl presented with AESD, characterized by biphasic seizures and later diffusion restriction on MRI.
- Serum procalcitonin (PCT) levels peaked at 50.5 ng/mL on day 1, and C-reactive protein (CRP) peaked at 1.21 mg/dL on day 2.
- Neurological examination at discharge revealed persistent right spastic hemiparesis.
Findings:
- Magnetic resonance (MR) spectroscopy on day 23 showed decreased N-acetylaspartate and increased choline, indicating neuronal injury.
- The study highlights the potential utility of PCT and the PCT/CRP ratio in the early diagnosis of AESD.
- Correlation between MR spectroscopy findings and long-term neurological outcomes was observed.
Implications:
- This case represents the first reported instance of AESD in Europe.
- The findings suggest that PCT and CRP can serve as valuable early diagnostic markers for AESD.
- MR spectroscopy findings may help predict neurological deficits in patients with AESD, guiding clinical management and prognosis.
Abstract:
We report a case of a 22-month-old Spanish girl who presented acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). Serum procalcitonin (PCT) reached a maximum of 50.5 ng/mL on the first day whereas C-reactive protein (CRP) peaked at 1.21 mg/dL on the second. At the time of discharge, right spastic hemiparesis persisted. MR spectroscopy on day 23 revealed a decrease in N-acetylaspartate and an increase in choline. To our knowledge, we report the first case of AESD in Europe. These findings support the role of PCT and PCT/CRP ratio in the early diagnosis of AESD and correlation of MR spectroscopy findings with neurological outcome.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

